Table 1.
Patients’ demographics
| Characteristic | n=466 |
|---|---|
| Age (years) | |
| Median | 61 |
| Range | 25–88 |
| Gender | N (%) |
| Male | 146 (31.3) |
| Female | 320 (68.7) |
| Tumour Type | N (%) |
| Breast | 190 (40.8) |
| GI | 73 (15.7) |
| Gynaecological | 56 (12.0) |
| Head-Neck | 18 (3.9) |
| Lung | 23 (4.9) |
| Melanoma | 9 (1.9) |
| Neurological | 3 (0.6) |
| Pancreatic | 49 (10.5) |
| Rare Cancers | 13 (2.8) |
| Urological | 32 (6.9) |
| Treatment | N (%) |
| Chemotherapy | 223 (47.8) |
| Chemotherapy+mAb | 100 (21.5) |
| mAb alone | 128 (27.5) |
| HT+target therapies | 6 (1.3) |
| Small molecules | 4 (0.9) |
| Radiotherapy | 2 (0.4) |
| Other | 3 (0.6) |
GI, gastrointestinal; HT, hormonal therapy; mAb, monoclonal antibody.